Skip to main content

and
  1. Article

    Open Access

    A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens

    The emergence of multidrug-resistant (MDR) Gram-negative pathogens is an urgent global medical challenge. The old polymyxin lipopeptide antibiotics (polymyxin B and colistin) are often the only therapeutic opt...

    Kade D. Roberts, Yan Zhu, Mohammad A. K. Azad, Mei-Ling Han in Nature Communications (2022)

  2. Article

    Open Access

    A polytherapy based approach to combat antimicrobial resistance using cubosomes

    A depleted antimicrobial drug pipeline combined with an increasing prevalence of Gram-negative ‘superbugs’ has increased interest in nano therapies to treat antibiotic resistance. As cubosomes and polymyxins d...

    **angfeng Lai, Mei-Ling Han, Yue Ding, Seong Hoong Chow in Nature Communications (2022)

  3. Article

    Open Access

    Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii

    Multidrug-resistant Acinetobacter baumannii presents a global medical crisis and polymyxins are used as the last-line therapy. This study aimed to identify metabolic differences between polymyxin-susceptible and ...

    Mohd Hafidz Mahamad Maifiah, Soon-Ee Cheah, Matthew D. Johnson in Scientific Reports (2016)